THC

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the hospital chains industry, including Tenet Healthcare (NYSE:THC) and its peers. Hospital chains operate scale-driven businesses that rely on patient volumes, efficient operations, and favorable payer contracts to drive revenue and profitability. These organizations benefit from the essential nature of their services, which ensures consistent demand, particularly as populations age and chronic diseases become more prevalent. However, profitability can be pressured by rising labor costs, regulatory requirements, and the challenges of balancing care quality with cost efficiency. Dependence on government and private insurance reimbursements also introduces financial uncertainty. Looking ahead, hospital chains stand to benefit from tailwinds such as increasing healthcare utilization driven by an aging population that generally has higher incidents of disease. AI can also be a tailwind in areas such as predictive analytics for more personalized treatment and efficiency (intake, staffing, resourcing allocation). However, the sector faces potential headwinds such as labor shortages that could push up wages as well as substantial investments needs for digital infrastructure to support telehealth and electronic health records. Regulatory scrutiny, and reimbursement cuts are also looming topics that could further strain margins. The 4 hospital chains stocks we track reported a mixed Q1. As a group, revenues beat analysts’ consensus estimates by 0.7% while next quarter’s revenue guidance was 2.7% below. Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 6.6% since the latest earnings results. With a network spanning nine states and serving primarily urban and suburban communities, Tenet Healthcare (NYSE:THC) operates a nationwide network of hospitals, ambulatory surgery centers, and outpatient facilities providing acute care and specialty healthcare services. Tenet Healthcare reported revenues of $5.37 billion, up 2.8% year on year. This print was in line with analysts’ expectations, and overall, it was a satisfactory quarter for the company with a beat of analysts’ EPS estimates but full-year revenue guidance slightly missing analysts’ expectations. Tenet Healthcare delivered the weakest performance again...

In recent sessions, Tenet Healthcare has attracted attention as investors look ahead to its July 24, 2026 earnings report, where analysts expect higher earnings per share and revenue than a year earlier. What stands out is the combination of upbeat earnings projections, favorable analyst rankings and continued operational focus, which together are shaping investor expectations around the company. With shares posting gains over the past week, we’ll examine how optimism around Tenet Healthcare’s upcoming earnings shapes its investment narrative. The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 15 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. To own Tenet Healthcare, you need to be comfortable with a story built around disciplined operations, significant share repurchases and a balance sheet that still carries a high level of debt. The latest move higher in the share price, helped by upbeat earnings projections for the July 24, 2026 report and a favorable Zacks Rank, reinforces earnings momentum and buyback-driven EPS strength as key short term catalysts rather than changing them. What does shift slightly with this news is the risk/reward balance around valuation and sentiment: shares are now trading above one estimate of fair value, recent insider selling has picked up and analyst targets and community fair values sit well above the current price. Together, that combination keeps execution, leverage and capital allocation decisions front and center for investors. However, Tenet’s high debt load remains a risk investors should understand in detail. Tenet Healthcare's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be. Four Simply Wall St Community fair value views span roughly US$211 million to a very large US$471 million range, underlining how differently investors see Tenet’s prospects as debt and earnings quality stay in focus. Explore 4 other fair value estimates on Tenet Healthcare - why the stock might be worth just $211.29! Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts. A great starting point for your Tenet Healthcare...

The Zacks Medical-Hospital industry is undergoing a structural transformation as patients and payers increasingly shift toward lower-cost care settings outside traditional hospitals. As a result, the fastest growth is coming from ambulatory surgery centers, home health and post-acute care providers. Meanwhile, hospitals continue to contend with elevated patient utilization, persistent labor and supply cost inflation, and reimbursement and regulatory uncertainty. To protect margins, providers are accelerating investments in AI, revenue cycle management and digital technologies, while streamlining operations and expanding outpatient care networks.Strategic mergers and acquisitions also remain an important growth lever to expand scale, improve efficiency and strengthen market presence. Companies like Tenet Healthcare Corporation THC, Universal Health Services, Inc. UHS, Acadia Healthcare Company, Inc. ACHC and Community Health Systems, Inc. CYH are streamlining operations, strengthening cost discipline and investing in higher-growth service lines. Industry Overview The Zacks Medical-Hospital industry comprises for-profit hospital companies that provide healthcare through different types of hospitals, including acute care, outpatient, rehabilitation and psychiatric. These entities are engaged in internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, telehealth, mental health and diagnostic and emergency services. Revenues of these companies depend on inpatient occupancy, medical and ancillary services ordered by physicians and provided to patients, and the volume of ambulatory surgery centers’ (ASC) procedures. These companies receive payments for patient services from the government under the Medicare program, Medicaid, or similar programs, managed care plans (including plans offered through the American Health Benefit Exchanges), private insurers and directly from patients. 4 Key Trends Shaping the Hospital Industry Demand Grows as Care Moves Beyond Hospitals: Demand for healthcare continues to rise, supported by an aging U.S. population, increasing chronic disease prevalence and higher use of elective procedures. CMS projects national health spending to climb steadily and reach around $9 trillion by 2034, making up 20.6% of the economy. Meanwhile, care is shifting away from traditional inpatient hospitals toward am...

Toronto, Ontario--(Newsfile Corp. - June 24, 2026) - Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) ("Tenet" or the "Company"), today announced its financial results and operating highlights for the three-month period ended March 31, 2026. Tenet reported revenue of $11,537,820 for the quarter, compared to $179,161 in the first quarter of 2025, and for the first time in the Company's history, Tenet reported a net profit of $728,475 for the first quarter of 2026, compared to a net loss of $3,372,597 in Q1-2025. All amounts in this news release are in Canadian dollars unless otherwise indicated. Q1-2026 Key Financial Figures Total Revenue of $11.54 million Net Profit of $728.48 thousand Cash flow from operations of $458.00 thousand Q1-2026 Operating Highlights The net profit reported by Tenet for the quarter can be attributed to just a handful of significant factors. Those include: the strong return of activity on the Company's GoldRiver supply-chain platform, which began in Q4-2025, and continued during the quarter; the transition of the Company's business model to emphasize data, AI and analytics, which led to an important decrease in fixed operational expenses; and the reversal of a provision related to the U.S. class action lawsuit against the Company and two of its executive officers, which was dismissed by the plaintiffs during the quarter. Some of Tenet's important achievements during the first quarter of 2026 to help bring the Company closer to its intended objective of becoming the global custodian of private SME data and leverage AI to become a global leader in business and economic intelligence include the following: Various enhancements to the Company's Cubeler Business Development Platform's Networking and Insights modules. Partnerships with 7 new accounting/bookkeeping service providers to bring more business client memberships to the Cubeler Business Development Platform. Full details of the Company's first quarter 2026 financial results can be found in the Unaudited Condensed Interim Consolidated Financial Statements and Management's Discussion and Analysis (MD&A) for the three-month periods ended March 31, 2026 and 2025, which are available under the Company's profile at www.sedarplus.ca. About Tenet Fintech Group Inc.: Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial i...

Toronto, Ontario--(Newsfile Corp. - June 24, 2026) - Tenet Fintech Group Inc. (CSE: PKK) (OTC PINK: PKKFF) ("Tenet" or the "Company"), today announced its financial results for the year ended December 31, 2025. The Company reported revenue of $10.39 million, compared to $2.84 million in 2024, and a net loss of $9.10 million for the year, compared to a net loss of $59.26 million in 2024. The Company generated negative cash flow from operations of $8.52 million, compared to negative $6.92 million in 2024. All amounts in this news release are in Canadian dollars unless otherwise indicated. 2025 Key Annual Financial Figures Total Revenue of $10.39 million Net Loss of $9.10 million Cash flow from operations of -$8.52 million The fourth quarter of 2025 marked a turning point for the Company, both from an operational standpoint and a revenue standpoint, with the return of full-scale activity on its GoldRiver supply-chain platform in China thanks to an agreement with a prominent real estate development group. $10.08 million of the Company's total revenue of $10.39 million for the year was generated in the quarter due in large part to that agreement. In addition to helping make a significant contribution to the Company's revenue, the new relationship allowed the Company to begin gathering important data on the Chinese real estate development and construction sectors, which the Company believes will enrich its macroeconomic data product offering now planned for launch in 2026. The launch of the Company's data product offering was originally expected by the end of 2025 but had to be postponed. The delay came primarily as a result of the failure-to-file cease trade order placed on the Company's securities by the Ontario Securities Commission in May 2025, which hampered the Company's financing activities for virtually the entire year. Although the Company was unable to invest in all of the necessary activities to commercialize its data product offering in 2025, noticeable improvements were made to the Cubeler Business Development Platform, through which the Company gathers the data from which the data products are derived, during the year. Q4 2025 Operating Highlights Some of Tenet's important achievements during the fourth quarter of 2025 to help bring the Company closer to its intended objective of becoming the global custodian of private SME data and leverage AI to be...

DALLAS, June 22, 2026--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its second quarter 2026 results before the market opens on Friday, July 24, 2026, to be followed by a conference call at 10:30 a.m. CT (11:30 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We also operate a national portfolio of acute care and specialty hospitals, other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve. For more information, please visit www.tenethealth.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260622294988/en/ Contacts Investor ContactWill [email protected] Media ContactOlivia E. [email protected]

Auna S.A. AUNA, the Latin America-based healthcare provider, is set to release first-quarter 2026 results on May 19, after the closing bell. The Zacks Consensus Estimate for the company’s first-quarter earnings per share (EPS) suggests flat year-over-year growth to 19 cents. The estimate has moved up 1 cent in the past 30 days. The consensus mark for first-quarter revenues currently stands at $318.3 million, suggesting 8.2% growth over the prior-year period. Image Source: Zacks Investment Research The company has a solid earnings surprise track record, having topped estimates in each of the trailing four quarters, with an average beat of 146.22%. Image Source: Zacks Investment Research Per our proven model, a stock with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), along with a positive Earnings ESP, has a higher chance of beating estimates. This is not the case here, as you can see below. Earnings ESP: Auna has an Earnings ESP of -2.70%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter. Zacks Rank: The company currently carries a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks Rank #1 stocks here. The company’s consolidated performance in 2025 reflected challenges in its Mexico operations. We assume soft market conditions may have prevailed in the region throughout the first quarter of 2026, affecting surgery volumes and emergency visits and weighing on revenues. However, Auna highlighted stabilization in Mexico in the previous quarter, which is likely to have positioned the business for sustained top-line and EBITDA growth this year. Under a new leadership team, the company has been working to expand its reach into the larger segments of privately insured families and strengthen alignment with certain physician groups. Auna is likely to have benefited from rolling out targeted pricing initiatives and pre-negotiated physician rates in the Out-of-Pocket segment. In the Institutional segment, the company was awarded an extension of an improved healthcare plan for ISSSTELEON employees, which may have further strengthened the margin profile of the partnership. The Oncology business is likely to have delivered another quarter of strong performance with the integration of Opcion Oncologia’s physician practice. The newly launched Oncocenter at the Doctors Hospital, which centralizes onco...

In late April 2026, Tenet Healthcare reported first-quarter 2026 results showing higher sales of US$5,368 million and increased net income of US$702 million, while also completing a share repurchase program totaling 10.91 million shares for US$1.83 billion under its July 24, 2024 authorization. The company also issued full-year 2026 guidance with projected net operating revenues of US$21.50–US$22.30 billion and diluted EPS of US$29.94–US$32.64, highlighting how margin gains and cost controls are feeding through to its earnings outlook. We’ll now examine how Tenet’s raised 2026 earnings guidance shapes its investment narrative and what it may mean for investors. The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation. For someone considering Tenet Healthcare, the core belief is that disciplined cost control and margin management can keep adding value even if revenue growth stays modest. The latest quarter reinforced that story: higher Q1 2026 earnings, expanded margins and a full-year EPS outlook of US$29.94 to US$32.64 suggest the company sees its efficiency gains as durable, at least near term. Completing an US$1.83 billion buyback at a time when the shares already trade below many fair value estimates amplifies earnings per share and underlines management’s confidence, which could be a short term support for the stock. At the same time, Tenet is still carrying a high debt load, and consensus expects earnings to soften over the next few years, so the bullish guidance slightly eases, but does not remove, the key risks. However, one risk in particular could catch investors off guard if conditions shift. Tenet Healthcare's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be. Four Simply Wall St Community fair value views span roughly US$211 million to almost US$491.80 million, underlining how far apart opinions can be. Set this against Tenet’s recent upbeat guidance and heavy use of buybacks, and you can see why it pays to weigh several perspectives on how sensitive the story is to execution and leverage. Explore 4 other fair value estimates on Tenet Healthcare - why the stock might be worth just $211.29! Don't just follow the ticker - dig into the data and build a conviction that's truly your own. A great...

Tenet Healthcare Corporation THC reported first-quarter 2026 adjusted earnings per share (EPS) of $4.82, which surpassed the Zacks Consensus Estimate by 14.5%. The bottom line increased 10.6% year over year. Net operating revenues advanced 2.8% year over year to $5.37 billion. The top line marginally missed the consensus mark by 0.4%. The quarterly results benefited from strong same-facility revenue growth and higher adjusted admissions, along with solid contributions from acquisitions that supported the Ambulatory Care segment. However, the upside was partly offset by an unfavorable payer mix and higher operating costs, particularly elevated supply expenses. Tenet Healthcare Corporation price-consensus-eps-surprise-chart | Tenet Healthcare Corporation Quote Adjusted net income of $422 million climbed 1.9% year over year in the quarter. Adjusted EBITDA of $1.2 billion surpassed our estimate of $1.1 billion, driven by solid same-facility revenue growth and disciplined expense management. However, the metric dipped 0.1% year over year due to an unfavorable payer mix, reflecting lower exchange admissions. Adjusted EBITDA margin contracted 70 basis points year over year to 21.6%. Salaries, wages and benefits increased 2.6% year over year to $2.2 billion in the first quarter, while supply costs rose 6% and net other operating expenses increased 2.9%. Ambulatory Care: The segment’s net operating revenues climbed 10.6% year over year to $1.3 billion in the quarter, driven by strong growth in consolidated same-facility net patient service revenues, contributions from facility acquisitions and an expansion of service lines. The metric topped our estimate by 2.3%. Adjusted EBITDA was $484 million, which advanced 6.1% year over year. The metric missed our estimate by 2.6%. Adjusted EBITDA margin deteriorated 150 bps year over year to 36.7%. Hospital Operations and Services: The segment recorded net operating revenues of $4.05 billion, which inched up 0.5% year over year driven by higher adjusted admissions, partly offset by an unfavorable payer mix. The metric missed our model estimate by 1.6%. Adjusted EBITDA decreased 4.1% year over year to $678 million in the quarter, affected by an unfavorable payer mix. Adjusted EBITDA margin of 16.7% was down 80 bps year over year. Tenet Healthcare exited the first quarter with cash and cash equivalents of $2.97 billion, which im...

Tenet reported Q1 net operating revenues of $5.4 billion and consolidated adjusted EBITDA of $1.16 billion (21.6% margin), beat prior expectations, generated $978 million of adjusted free cash flow, held $2.97 billion cash, repurchased 1.35 million shares for $318 million, and reaffirmed full‑year 2026 guidance. Segment results were mixed but strong overall: USPI posted adjusted EBITDA of $484 million (36.7% margin) with 5.3% same‑facility revenue growth, while hospitals delivered $678 million of EBITDA (16.7% margin) with modest inpatient admission growth offset by a 41% drop in respiratory cases. Management highlighted payer‑mix headwinds—exchange admissions down about 10% and exchange revenues down roughly 9–10% YoY, plus some Medicaid softness—while pushing a strategy toward higher‑acuity care and AI/process automation pilots to improve throughput and reduce costs. Interested in Tenet Healthcare Corporation? Here are five stocks we like better. Top Analyst-Rated Healthcare Stocks to Watch Now Tenet Healthcare (NYSE:THC) reported first-quarter 2026 net operating revenues of $5.4 billion and consolidated adjusted EBITDA of $1.16 billion, for an adjusted EBITDA margin of 21.6%, as management cited disciplined expense execution, stable volumes despite coverage-related headwinds, and strong free cash flow generation. Chairman and CEO Dr. Saum Sutaria said results came in “above our previously provided expectations,” even as the company navigated “payer mix shifts, seasonal effects, and insurance enrollment uncertainty in the exchanges and Medicaid that impact demand.” CFO Sun Park said operating expense performance benefited from progress on initiatives discussed in the prior quarter and contributed to the margin outcome. → 5 Stocks to Buy in May Before the Next AI Surge Hits 3 Under-the-Radar Healthcare Companies In the ambulatory segment, USPI generated adjusted EBITDA of $484 million, up 6% from the first quarter of 2025, with an adjusted EBITDA margin of 36.7%. Sutaria said USPI posted “a robust 22%” of full-year 2026 adjusted EBITDA guidance in the first quarter, and noted a recent pattern of earnings shifting modestly toward the first quarter. USPI same-facility system-wide revenues grew 5.3% year over year. Park said net revenue per case increased 5.6% while same-facility case volumes declined 0.3%, with volumes impacted by winter storms. Sutaria said...

Tenet Healthcare (THC) shares were trading slightly higher Thursday as the company reported higher Q

Tenet Healthcare (THC) reported $5.37 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 2.8%. EPS of $4.82 for the same period compares to $4.36 a year ago. The reported revenue represents a surprise of -0.36% over the Zacks Consensus Estimate of $5.39 billion. With the consensus EPS estimate being $4.21, the EPS surprise was +14.39%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Tenet performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Adjusted patient admissions - Same-hospital: 210.85 thousand versus 212.31 thousand estimated by two analysts on average. Adjusted admissions: 215.35 thousand versus the two-analyst average estimate of 208.48 thousand. Net Operating revenues: $5.37 billion versus the four-analyst average estimate of $5.37 billion. The reported number represents a year-over-year change of +2.8%. Net Operating revenues- Ambulatory Care: $1.32 billion compared to the $1.3 billion average estimate based on four analysts. The reported number represents a change of +10.6% year over year. Net Operating revenues- Hospital Operations and Services: $4.05 billion versus the four-analyst average estimate of $4.07 billion. The reported number represents a year-over-year change of +0.5%. Equity in earnings of unconsolidated affiliates: $51 million versus $57.66 million estimated by four analysts on average. Equity in earnings of unconsolidated affiliates- Ambulatory Care: $51 million compared to the $55.55 million average estimate based on three analysts. Adjusted EBITDA- Hospital Operations and Services: $678 million versus the three-analyst average estimate of $622.37 million. Adjusted EBITDA- Ambulatory Care: $484 million versus $487.14 million estimated by three analysts on average. View all Key Company Metrics for Tenet here>>> Shares of Tenet have returned -5.4% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stoc...